SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-17-001973
Filing Date
2017-07-24
Accepted
2017-07-24 17:11:45
Documents
1
Period of Report
2017-07-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form310959006a_07242017.html 3  
1 OWNERSHIP DOCUMENT form310959006a_07242017.xml 3 4308
  Complete submission text file 0000921895-17-001973.txt   6323
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 122 E.42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address
Lipman Matthew E. (Reporting) CIK: 0001687758 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21214 | Film No.: 17978828

Mailing Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168 212-302-0699
BP Peptides, LLC (Reporting) CIK: 0001711689 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 000-21214 | Film No.: 17978827